Tripeptide-29 is the synthetic peptide consisting of glycine, proline and hydroxyproline.
CAT No: CPC1682
CAS No:2239-67-0
Synonyms/Alias:H-Gly-Pro-Hyp-OH;2239-67-0;Glycylprolylhydroxyproline;Tripeptide-29;Tripeptide 29;X6346H6PUM;L-Proline, glycyl-L-prolyl-4-hydroxy-, (4R)-;(2S,4R)-1-[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carboxylic acid;(2S,4R)-1-(((2S)-1-(Aminoacetyl)-2-pyrrolidinyl)carbonyl)-4-hydroxy-2-pyrrolidinecarboxylic acid;H-Gly-Pro-Hyp-OH (acetate);(2S,4R)-1-((S)-1-(2-Aminoacetyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid;glycyl-prolyl-hydroxyproline;MFCD00037343;UNII-X6346H6PUM;SCHEMBL3942552;CHEBI:193240;SZEOBSAZWJLOGY-VGMNWLOBSA-N;DTXSID801311276;HY-A0299;DA-74148;FG109052;CS-0137730;G77515;
2. Cationic cell-penetrating peptides are potent furin inhibitors
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.